Analysis of the efficacy and safety of the compound tablets of levonorgestrel and estradiol in the treatment of polycystic ovary syndrome
Objective To explore the effectiveness and safety of the treatment of polycystic ovary syndrome with levonorgestrel estradiol complex tablets.Methods 116 patients with polycystic ovary syndrome admitted to our hospital were selected as the study subjects and randomly divided into two groups,with 58 cases in each group.The control group was treated with ethinyl estradiol cycloproterenol tablets,while the experimental group was treated with drospirone ethinyl estradiol composite tablets.Results The therapeutic effects of the two groups were compared.The total effective rate of the experimental group was 93.1％,which was higher than the control group's 79.3％(P＜0.05);The incidence of adverse reactions in the experimental group was 3.4％,lower than the control group's 13.8％(P＜0.05);After treatment,the levels of luteinizing hormone,follicle stimulating hormone,fasting insulin,insulin resistance index,total cholesterol,and triglycerides in the experimental group were lower than those in the control group(P＜0.05).Conclusion The treatment of polycystic ovary syndrome with levonorgestrel estradiol composite tablets has significant efficacy and high safety.It can effectively improve the patient's sex hormone levels and reduce the impact on their glucose and lipid metabolism,and can be widely used.
NETL
NSTL
万方数据
